The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Clopidogrel/Acetylsalicylic acid Mylan

75 mg/100 milligram(s) Film-coated tablet

Mylan S.A.S.EU/1/19/1395/006-010

Main Information

Trade NameClopidogrel/Acetylsalicylic acid Mylan
Active SubstancesClopidogrel hydrogen sulphate
Acetylsalicylic acid
Strength75 mg/100 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMylan S.A.S.
Licence NumberEU/1/19/1395/006-010

Group Information

ATC CodeB01AC30 combinations


Licence Issued09/01/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0043-031-003
Interchangeable List DocumentPDF of Interchangeable List
« Back